DK3313987T3 - Fremgangsmåde til produktion i stor målestok samt oprensning af parvovirus - Google Patents

Fremgangsmåde til produktion i stor målestok samt oprensning af parvovirus Download PDF

Info

Publication number
DK3313987T3
DK3313987T3 DK16736792.9T DK16736792T DK3313987T3 DK 3313987 T3 DK3313987 T3 DK 3313987T3 DK 16736792 T DK16736792 T DK 16736792T DK 3313987 T3 DK3313987 T3 DK 3313987T3
Authority
DK
Denmark
Prior art keywords
parvovirus
purification
procedure
large scale
scale production
Prior art date
Application number
DK16736792.9T
Other languages
English (en)
Inventor
Barbara Leuchs
Mandy Roscher
MARCUS MüLLER
Jean Rommelaere
Original Assignee
Deutsches Krebsforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deutsches Krebsforsch filed Critical Deutsches Krebsforsch
Application granted granted Critical
Publication of DK3313987T3 publication Critical patent/DK3313987T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02Recovery or purification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14323Virus like particles [VLP]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14351Methods of production or purification of viral material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14361Methods of inactivation or attenuation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
DK16736792.9T 2015-06-23 2016-06-22 Fremgangsmåde til produktion i stor målestok samt oprensning af parvovirus DK3313987T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15173385 2015-06-23
PCT/EP2016/001066 WO2016206807A1 (en) 2015-06-23 2016-06-22 Method for large scale production and purification of parvovirus

Publications (1)

Publication Number Publication Date
DK3313987T3 true DK3313987T3 (da) 2020-02-03

Family

ID=53488222

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16736792.9T DK3313987T3 (da) 2015-06-23 2016-06-22 Fremgangsmåde til produktion i stor målestok samt oprensning af parvovirus

Country Status (8)

Country Link
US (1) US10266810B2 (da)
EP (1) EP3313987B1 (da)
JP (1) JP6608969B2 (da)
AU (1) AU2016284488B2 (da)
CA (1) CA2988446C (da)
DK (1) DK3313987T3 (da)
ES (1) ES2765999T3 (da)
WO (1) WO2016206807A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2018227883B2 (en) * 2017-03-03 2022-08-04 Takeda Pharmaceutical Company Limited Methods for determining potency of Adeno-associated virus preparations
EP3768865B1 (en) * 2018-03-23 2022-12-14 Life Technologies Corporation Methods and kits to detect viral particle heterogeneity
EP3754015A1 (en) 2019-06-17 2020-12-23 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Optimized parvovirus h-1 production
CN112359140A (zh) * 2020-11-06 2021-02-12 苏州药明检测检验有限责任公司 一种利用空斑染色测定鼠细小病毒滴度的方法
WO2023052429A1 (en) * 2021-09-30 2023-04-06 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Method for further upscaling the large-scale production of the oncolytic h-1 protoparvovirus (h-1pv) using a carrier-based production process combined with an optimized cell culture medium

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1944362T3 (da) * 1997-09-05 2016-01-25 Genzyme Corp Fremgangsmåder til fremstilling af hjælpevirusfri præparater med høj titer af rekombinante AAV-vektorer
US20100303776A1 (en) * 2009-04-16 2010-12-02 The University Of North Carolina At Chapel Hill Methods and compositions for regulated expression of multiple nucleic acids
DK2332986T3 (da) * 2009-12-11 2013-12-16 Deutsches Krebsforsch Antistof som binder til H-1 parvovirus
EP2397542A1 (en) * 2010-06-17 2011-12-21 Deutsches Krebsforschungszentrum Modified parvovirus having enhanced anti-tumour efficacy
EP2404609A1 (en) 2010-07-07 2012-01-11 Deutsches Krebsforschungszentrum Use of parvovirus for eliminating cancer stem cells (CSCs)
EP2535055A1 (en) * 2011-06-15 2012-12-19 Deutsches Krebsforschungszentrum Oncolytic virotherapy for therapy of bone cancer
US11078464B2 (en) 2013-08-30 2021-08-03 Amgen Inc. High titer recombinant AAV vector production in adherent and suspension cells

Also Published As

Publication number Publication date
AU2016284488B2 (en) 2018-05-31
ES2765999T3 (es) 2020-06-11
AU2016284488A1 (en) 2018-01-18
EP3313987B1 (en) 2019-10-23
WO2016206807A1 (en) 2016-12-29
US20180187166A1 (en) 2018-07-05
JP6608969B2 (ja) 2019-11-20
JP2018523992A (ja) 2018-08-30
CA2988446A1 (en) 2016-12-29
CA2988446C (en) 2020-07-21
EP3313987A1 (en) 2018-05-02
US10266810B2 (en) 2019-04-23

Similar Documents

Publication Publication Date Title
DK3512850T3 (da) Inhibitorer af menin-mll-interaktionen
DK3468966T3 (da) Inhibitorer af menin-mll-interaktionen
DK3172227T3 (da) Molekyler der selektivt aktiverer regulatoriske t-celler til behandlingen af autoimmune sygdomme
DK3192902T3 (da) Fremgangsmåde til fremstilling af graphenholdige viscosefibre
DK3119397T3 (da) Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser
DK3637269T3 (da) Forvaltning af lagerenheder
DK3112249T3 (da) System til behandling af boil-off-gas
DK3137169T3 (da) Hæmmere af lysin-specifik demethylase-1
DK3292134T3 (da) Metode til dyrkning af akkermansia
DK3102576T3 (da) Dihydropyrrolopyridininhibitorer af ror-gamma
DK3125875T3 (da) Inhalerbar rapamycinformulering til behandling af aldersrelaterede tilstande
DK2964315T3 (da) System til behandling af neuromotorisk dysfunktion
DK3250660T3 (da) Fremgangsmåde til hydrotermal oprensning
DK3325443T3 (da) Fremgangsmåde til fremstilling af pridopidin
DK3317400T3 (da) Fremgangsmåde til kryokonservering af tumorinfiltrerende lymfocytter
DK3164380T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3307296T3 (da) Timp2 til anvendelse til behandling af aldringsassocierede tilstande
DK3390390T3 (da) Bipyrazolylderivater egnede til behandling af autoimmunsygdomme
DK3099298T3 (da) Kombinationsterapier med zidovudin til behandling af mikrobielle infektioner
DK3113858T3 (da) Fremgangsmåde til oprensning af il-15/il-15ralpha-baserede konjugater
DK3077345T3 (da) System på grundlag af plantematerialer eller af biologisk oprindelse
DK3176906T3 (da) Tostrenget batteriløsning til backcup af datacenter
DK3313987T3 (da) Fremgangsmåde til produktion i stor målestok samt oprensning af parvovirus
BR112018006551A2 (pt) conjunto de porca bipartida
DK3261661T3 (da) Menotropin til behandling af infertilitet